Enhancement of the effects of a complete inhibitor of enkephalin-catabolizing enzymes, RB 101, by a cholecystokinin-B receptor antagonist in diabetic rats

1. RB 101, a complete inhibitor of enkephalin-catabolizing enzymes, has been previously shown to produce antinociception in normal rats after systemic administration. Moreover, its coadministration with a cholecystokinin-B (CCK-B) receptor antagonist has been shown to strongly enhance its antinocice...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Coudoré-Civiale, Marie-Ange, Méen, Murielle, Fournié-Zaluski, Marie-Claude, Boucher, Michel, Roques, Bernard P, Eschalier, Alain
Formato: Artigo
Idioma:Inglês
Publicado em: 2001
Assuntos:
Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1572770/
https://ncbi.nlm.nih.gov/pubmed/11325808
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0704059
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados